(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -15.48%20.81B | -14.33%14.25B | -13.10%6.51B | -7.96%37B | -8.60%24.63B | -9.52%16.63B | 7.92%7.49B | 4.81%40.2B | 6.36%26.94B | 2.90%18.38B |
Special items of operating revenue | 118.50%125.67M | 146.72%81.95M | 204.98%38.05M | 419.25%85.19M | --57.51M | --33.22M | --12.48M | --16.41M | ---- | ---- |
Operating income | -15.17%20.94B | -14.00%14.33B | -12.74%6.55B | -7.79%37.09B | -8.39%24.68B | -9.34%16.67B | 8.10%7.5B | 4.85%40.22B | 6.36%26.94B | 2.90%18.38B |
Operating expenses | 20.84%-14.56B | 19.35%-10.07B | 18.42%-4.73B | 10.46%-27.47B | 11.74%-18.39B | 11.60%-12.48B | -9.83%-5.79B | -2.79%-30.68B | -7.39%-20.83B | -2.76%-14.12B |
Gross profit | 1.39%6.38B | 1.94%4.27B | 6.49%1.82B | 0.80%9.62B | 3.03%6.3B | -1.85%4.18B | 2.61%1.71B | 12.07%9.54B | 2.97%6.11B | 3.37%4.26B |
Selling expenses | 1.07%-547.81M | -5.27%-361.11M | -2.25%-174.26M | -9.96%-893.03M | -8.29%-553.72M | -10.22%-343.04M | -5.16%-170.43M | -1.93%-812.11M | 8.68%-511.33M | 13.93%-311.24M |
Administrative expenses | -0.55%-1.47B | 1.47%-955.97M | -5.38%-488.17M | -2.00%-2.34B | 1.91%-1.46B | -1.55%-970.23M | -5.27%-463.26M | -8.17%-2.29B | -0.14%-1.49B | 2.71%-955.4M |
Research and development expenses | -6.89%-1.16B | -15.68%-750.41M | -22.98%-376.27M | -10.21%-1.86B | -0.53%-1.09B | -0.02%-648.67M | -6.14%-305.95M | -3.13%-1.69B | -10.54%-1.08B | -0.80%-648.57M |
Profit from asset sales | 32,192.95%42.52M | -116.40%-37.84K | -766.67%-324.16K | -99.78%63.7K | -99.56%131.66K | -99.14%230.7K | 70.12%-37.4K | -17.66%29.6M | 12.05%29.66M | 5.86%26.78M |
Impairment and provision | -40.07%-132.82M | -10.11%-83.05M | 163.68%70.15M | 17.15%-461.56M | 30.67%-94.83M | 31.04%-75.42M | 163.87%26.6M | -114.10%-557.14M | -153.53%-136.78M | -87.37%-109.37M |
-Other impairment is provision | -40.07%-132.82M | -10.11%-83.05M | 163.68%70.15M | 17.15%-461.56M | 30.67%-94.83M | 31.04%-75.42M | 163.87%26.6M | -114.10%-557.14M | -153.53%-136.78M | -87.37%-109.37M |
Operating interest expense | -2,084.50%-10.54M | -3,704.17%-5.5M | ---1.36M | ---732.17K | ---482.39K | ---144.56K | ---- | ---- | ---- | ---- |
Special items of operating profit | -25.08%285.27M | -38.96%182.19M | -51.73%58.5M | 13.75%555.59M | -4.04%380.75M | -6.79%298.49M | -21.70%121.19M | 8.34%488.42M | 94.97%396.78M | 125.10%320.23M |
Operating profit | -3.14%3.23B | -7.00%2.17B | -2.71%855.37M | -2.37%4.36B | 5.04%3.33B | -5.40%2.34B | 4.52%879.24M | 13.59%4.47B | 8.01%3.17B | 15.38%2.47B |
Financing cost | -72.85%54.63M | -44.62%79.37M | -57.08%24.3M | 26.15%300.23M | -39.03%201.2M | -23.68%143.31M | 37.26%56.62M | -23.82%237.98M | 34.40%330M | -8.30%187.78M |
Special items of earning before tax | 54.90%21.9M | -14.97%8.59M | 54.60%7.02M | -23.33%29.44M | -44.65%14.14M | -2.46%10.1M | 24.92%4.54M | 30.11%38.4M | 11.53%25.54M | -60.60%10.36M |
Earning before tax | -6.86%3.3B | -9.20%2.26B | -5.71%886.7M | -1.11%4.69B | 0.55%3.55B | -6.67%2.49B | 6.13%940.4M | 10.97%4.74B | 10.06%3.53B | 12.49%2.67B |
Tax | 2.45%-579.88M | -5.22%-403.21M | -6.21%-173.91M | -5.20%-675.45M | -2.88%-594.43M | 19.71%-383.19M | -11.29%-163.74M | -10.51%-642.05M | -8.34%-577.78M | -41.78%-477.27M |
After-tax profit from continuing operations | -7.75%2.72B | -11.82%1.86B | -8.22%712.79M | -2.09%4.01B | 0.10%2.95B | -3.83%2.11B | 5.10%776.66M | 11.04%4.1B | 10.40%2.95B | 7.65%2.19B |
Earning after tax | -7.75%2.72B | -11.82%1.86B | -8.22%712.79M | -2.09%4.01B | 0.10%2.95B | -3.83%2.11B | 5.10%776.66M | 11.04%4.1B | 10.40%2.95B | 7.65%2.19B |
Minority profit | -5.51%363.87M | -8.60%260.26M | 9.73%108.3M | 15.10%537.51M | 10.95%385.08M | 10.15%284.74M | 8.53%98.69M | 11.66%467M | 32.81%347.06M | 31.73%258.51M |
Profit attributable to shareholders | -8.09%2.36B | -12.32%1.6B | -10.84%604.49M | -4.30%3.48B | -1.35%2.57B | -5.70%1.82B | 4.62%677.96M | 10.96%3.63B | 7.97%2.6B | 5.08%1.93B |
Basic earnings per share | -8.33%0.22 | -11.76%0.15 | 0.00%0.06 | -3.03%0.32 | -4.00%0.24 | -5.56%0.17 | 0.00%0.06 | 10.00%0.33 | 13.64%0.25 | 12.50%0.18 |
Diluted earnings per share | -8.33%0.22 | -11.76%0.15 | 0.00%0.06 | -3.03%0.32 | -4.00%0.24 | -5.56%0.17 | 0.00%0.06 | 10.00%0.33 | 13.64%0.25 | 12.50%0.18 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data